Recombinant protective antigen anthrax vaccine (PharmAthene/IMV)

N/A

Report date: 2025/03/20 09:43:54

Base Information

Drug NameRecombinant protective antigen anthrax vaccine (PharmAthene/IMV)
Drug Alias NameRecombinant protective antigen anthrax vaccine (Altimmune/Immunovaccine)Recombinant protective antigen anthrax vaccine (PharmAthene/Immunovaccine)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmathene Inc
China Registration ClassN/A

Develop Information

Active CompaniesAltimmune IncIMV Inc
Inactive CompaniesPharmathene Inc
Active IndicationsAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A